<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000344.v1.p1" parentStudy="phs000344.v1.p1" createDate="2011-03-02" modDate="2011-06-23">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigators</td><td>Bryan J. Traynor</td><td>Neuromuscular Diseases Research Group, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Principal Investigators</td><td>Pentti J. Tienari</td><td>Department of Neurology, Helsinki University Central Hospital and Molecular Neurology Programme, Biomedicum, University of Helsinki, Helsinki, Finland</td></tr>
		<tr><td>Co-Investigators</td><td>Hannu Laaksovirta</td><td>Department of Neurology, Helsinki University Central Hospital and Molecular Neurology Programme, Biomedicum, University of Helsinki, Helsinki, Finland</td></tr>
		<tr><td>Co-Investigators</td><td>Terhi Peuralinna</td><td>Department of Neurology, Helsinki University Central Hospital and Molecular Neurology Programme, Biomedicum, University of Helsinki, Helsinki, Finland</td></tr>
		<tr><td>Co-Investigators</td><td>Jennifer C. Schymick</td><td>Neuromuscular Diseases Research Group, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Genome-Wide Association Study of Amyotrophic Lateral Sclerosis in Finland</StudyNameEntrez>
	<StudyNameReportPage>Genome-Wide Association Study of Amyotrophic Lateral Sclerosis in Finland</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The genetic etiology of amyotrophic lateral sclerosis (ALS) is not well understood. Finland has one of the highest incidence 	of ALS in the world, making it an ideal population for study. To identify genetic risk factors for this fatal neurodegenerative 	disease, we undertook a genome-wide association study of 405 Finnish patients diagnosed with ALS and 497 Finnish controls. 	Two loci that exceeded the Bonferroni threshold for genome-wide significance were identified. One was located on 	chromosome 21q22, corresponding to the known autosomal recessive D90A allele of the SOD1 gene. The other was detected on the 	short arm of chromosome 9, which had been previously identified in linkage studies of families with ALS. Together, these two 	loci account for most of the increased incidence of ALS observed in this population.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><b>Inclusion/exclusion criteria for cases</b></p> 	<p>All DNA samples were obtained from patients who: 		<ol type="i"> 			<li>had been diagnosed with ALS according to the El Escorial diagnostic criteria published by the World Federation of Neurology;</li> 			<li>were White and non-Hispanics (by self-report);</li> 			<li>were Finnish (by self-report);</li> 			<li>had signed informed consent.</li> 		</ol> 	</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="20801718"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Amyotrophic Lateral Sclerosis"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigators">
			<AttName>Bryan J. Traynor</AttName>
			<Institution>Neuromuscular Diseases Research Group, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Principal Investigators">
			<AttName>Pentti J. Tienari</AttName>
			<Institution>Department of Neurology, Helsinki University Central Hospital and Molecular Neurology Programme, Biomedicum, University of Helsinki, Helsinki, Finland</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Hannu Laaksovirta</AttName>
			<Institution>Department of Neurology, Helsinki University Central Hospital and Molecular Neurology Programme, Biomedicum, University of Helsinki, Helsinki, Finland</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Terhi Peuralinna</AttName>
			<Institution>Department of Neurology, Helsinki University Central Hospital and Molecular Neurology Programme, Biomedicum, University of Helsinki, Helsinki, Finland</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Jennifer C. Schymick</AttName>
			<Institution>Neuromuscular Diseases Research Group, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Sonja W. Scholz</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Shiao-Lin Lai</AttName>
			<Institution>Neuromuscular Diseases Research Group, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Liisa Myllykangas</AttName>
			<Institution>Department of Pathology, Haartman Institute, University of Helsinki and Folkh&#228;lsan Research Center, Helsinki, Finland</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Raimo Sulkava</AttName>
			<Institution>Section of Geriatrics, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Lilja Jansson</AttName>
			<Institution>Neuromuscular Diseases Research Group, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Dena Hernandez</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>J. Raphael Gibbs</AttName>
			<Institution>Computational Biology Core, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>Michael Nalls</AttName>
			<Institution>Molecular Genetics Unit, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigators">
			<AttName>David Heckerman</AttName>
			<Institution>Microsoft Research, Los Angeles, CA, USA</Institution>
		</Header>
		<Header title="Funding">
			<AttName>Project Z01 AG000949-02</AttName>
			<Institution>Intramural Research Program of the National Institute on Aging, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>The current data release is in conjunction with our Lancet Neurology paper (Laaksovirta et al., 2010). This release of data 	includes 896 samples for which participants provided consent to make their data publicly available. Six samples were removed for    quality control reasons.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NINDS</DacName>
      <DacFullName>National Institute of Neurological Disorders and Stroke</DacFullName>
      <DacEmail>ninds-dac@mail.nih.gov</DacEmail>
      <DacPhone></DacPhone>
      <DacFax>301-402-1501</DacFax>
      <DacUrl>http://grants.nih.gov/grants/gwas</DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000344.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>3</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
               http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000344.v1.p1
            </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000344.v1.p1" FileName="TraynorlNINDSDUC_2011.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use for research purposes only.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
